- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07653724
Radicle Energy VBMTM: A Study Assessing the Impact of Health and Wellness Products on Fatigue and Related Health Outcomes
Radicle Energy VBMTM: A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Impact of Health and Wellness Products on Fatigue and Related Health Outcomes
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
This is a randomized, double-blind, placebo-controlled study conducted with adult participants, residing in the United States. Eligible participants will (1) consume less than 3 caffeinated beverages a day, (2) have the opportunity for meaningful improvement (at least 30%) in their primary health outcome, and (3) express acceptance in taking a product and not knowing its formulation until the end of the study.
Participants that report a known contraindication or with well- established, significant safety concerns due to illness will be
excluded. Heavy drinkers and those who report they are pregnant, trying to become pregnant, or breastfeeding will be excluded. Participants that report taking medications with a known contraindication or with well-established, significant safety concerns will be excluded. Self-reported data are collected electronically from eligible participants for 7 weeks. Participant reports of health indicators will be collected at enrollment and throughout the active period of study product usage. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Study Manager
- Telefonnummer: 858-779-0086
- E-mail: studymgmt@radiclescience.com
Undersøgelse Kontakt Backup
- Navn: Susan Hewlings
- E-mail: susan.hewlings@radiclescience.com
Studiesteder
-
-
California
-
Del Mar, California, Forenede Stater, 92014
- Radicle Science Inc.
-
Kontakt:
- Study Manager
- Telefonnummer: 760-281-3898
- E-mail: studymgmt@radiclescience.com
-
Kontakt:
- Megan Mosely
- E-mail: megan@radiclescience.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Participants must meet all the following criteria:
Adults, at least 21 years of age at the time of electronic consent, inclusive of all ethnicities, races, and gender identities
- Assigned sex at birth will determine sex-specific recruitment and PROs (male vs female) employed, when needed
- Resides in the United States
- Has the opportunity for at least 30% improvement in their primary health outcome
- Expresses a willingness to take a study product and not know the product identity (active or placebo) until the end of the study
3.2 Exclusion
Individuals who report any of the following during screening may be excluded from participation:
- Report being pregnant, trying to become pregnant, or breastfeeding
- Unable to provide a valid US shipping address and mobile phone number
- Reports current enrollment in another clinical trial
- Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day)
- Unable to read and understand English at a 7th grade level
- Reports a current and/or recent (up to 3 months ago) major illness and/or surgery that poses a known, significant safety risk.
Reports a diagnosis of cardiac dysfunction, liver or kidney disease that presents a known contraindication and/or a significant safety risk with any of the study product ingredients.
- NYHA Class III or IV congestive heart failure, atrial fibrillation, uncontrolled arrhythmias, cirrhosis, end-stage liver disease, stage 3b or 4 chronic kidney disease, or kidney failure
Reports taking medications that have a well-established moderate or severe interaction, posing a substantial safety risk with any of the study product ingredients.
- Anticoagulants, antihypertensives, anxiolytics, antidepressants, chemotherapy, immunotherapy, sedative hypnotics, seizure medications, medications that warn against grapefruit consumption, corticosteroids at doses greater than 5 mg per day, diabetic medications, oral anti-infectives (antibiotics, antifungals, antivirals) to treat an acute infection, antipsychotics, MAOIs, or thyroid products
- Reports current use of caffeine-alternative products
- Reports consuming 3 or more caffeinated beverages a day
- Lack of reliable daily access to the internet
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Active Energy Product 1
Energy Active Product 1
|
Deltagerne vil bruge deres Energy Active Product 1 som anført i en periode på 6 uger.
|
|
Placebo komparator: Placebo Energy Control
Energy Product Placebo Control
|
Participants will use their Energy Product Placebo Control as directed for a period of 6 weeks.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Ændring i træthed
Tidsramme: 7 uger
|
Ændring i træthed: Forskel i ændringer over tid i træthedsscore som vurderet af Patient Reported Outcome Measurement System (PROMIS) Fatigue 8A (skala 8-40; hvor højere score svarer til mere alvorlig træthed)
|
7 uger
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Ændring i kognitiv funktion
Tidsramme: 7 uger
|
Ændring i kognitiv funktion: Forskel i ændringer over tid i kognitiv funktionsscore som vurderet af PROMIS kognitiv funktion 8A (skala 8-40; hvor lavere score svarer til dårligere kognitiv funktion)
|
7 uger
|
|
Ændring i søvn
Tidsramme: 7 uger
|
Ændring i søvn: Forskel i ændringer over tid i søvnscore som vurderet af PROMIS søvnforstyrrelse 8A (skala 8-40; hvor højere score svarer til højere niveauer af søvnforstyrrelser)
|
7 uger
|
|
Change in Global Mental Health
Tidsramme: 7 weeks
|
Change in Global Mental Health: Difference in rates of change over time in cognitive function score as assessed by PROMIS Global Mental Health 4A (scale 4-20; where lower scores correspond to worse cognitive function)
|
7 weeks
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Minimal klinisk vigtig forskel (MCID) i søvn
Tidsramme: 7 uger
|
Minimal klinisk vigtig forskel (MCID) i søvn: sandsynlighed for at opleve minimal klinisk vigtig forskel i søvn score som vurderet af Promis søvnforstyrrelse 8a (skala 8-40; hvor højere score svarer til højere niveauer af søvnforstyrrelse)
|
7 uger
|
|
Minimal klinisk vigtig forskel (MCID) i kognitiv funktion
Tidsramme: 7 uger
|
Minimal klinisk vigtig forskel (MCID) i kognitiv funktion: Sandsynligheden for at opleve minimal klinisk vigtig forskel i kognitiv funktionsscore vurderet af PROMIS kognitiv funktion 8A (skala 8-40; hvor lavere score svarer til dårligere kognitiv funktion)
|
7 uger
|
|
Minimal klinisk vigtig forskel (MCID) i træthed
Tidsramme: 7 uger
|
Minimal klinisk vigtig forskel (MCID) i træthed: Sandsynligheden for at opleve minimal klinisk vigtig forskel i træthedsscore vurderet af PROMIS Fatigue 8A (skala 8-40; hvor højere score svarer til mere alvorlig træthed)
|
7 uger
|
|
Minimal clinically important difference (MCID) in Global Mental Health
Tidsramme: 7 weeks
|
Minimal clinically important difference (MCID) in Global Mental Health: Likelihood of experiencing minimal clinically important difference in cognitive function score as assessed by PROMIS Global Mental Health (scale 4-20; where lower scores correspond to worse cognitive function)
|
7 weeks
|
|
Change in Cognitive Abilities
Tidsramme: 7 weeks
|
Change in Cognitive Abilities: Difference between rates of change over time in sleep score as assessed by PROMIS Cognitive Abilities 8a (scale 8-40; where the higher scores correspond to worse sleep)
|
7 weeks
|
|
Minimal clinically important difference (MCID) in Cognitive Abilities
Tidsramme: 7 weeks
|
Minimal clinically important difference (MCID) in Cognitive Abilities: Likelihood of experiencing minimal clinically important difference in sleep score, as measured by PROMIS Cognitive Abilities (scale 8-40; where the higher scores correspond to worse sleep)
|
7 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Susan Hewlings, Radicle Science
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- RADX_P_2604_VBM
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Energi aktivt produkt 1
-
Radicle ScienceAfsluttet
-
Radicle ScienceAfsluttetSmerte | Neuropatisk smerte | Nociceptiv smerteForenede Stater
-
Radicle ScienceAfsluttetKognitiv funktionForenede Stater
-
Radicle ScienceAfsluttet
-
Radicle ScienceAfsluttetSeksuel funktion | Seksuel tilfredsstillelseForenede Stater
-
Glaukos CorporationRekrutteringProgressiv KeratoconusForenede Stater
-
Radicle ScienceAfsluttetKognitiv funktionForenede Stater
-
Uskudar UniversityRekrutteringNakke smerter | Ikke-specifik nakkesmerterTyrkiet (Türkiye)
-
Pierre Fabre Dermo CosmetiqueAfsluttet
-
Miami Research AssociatesGlanbia Performance NutritionAfsluttet